{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05421663",
            "orgStudyIdInfo": {
                "id": "90014496LYM1001"
            },
            "secondaryIdInfos": [
                {
                    "id": "90014496LYM1001",
                    "type": "OTHER",
                    "domain": "Janssen Research & Development, LLC"
                },
                {
                    "id": "2023-506267-33-00",
                    "type": "REGISTRY",
                    "domain": "EUCT number"
                },
                {
                    "id": "2023-506267-33",
                    "type": "EUDRACT_NUMBER"
                }
            ],
            "organization": {
                "fullName": "Janssen Research & Development, LLC",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study of JNJ-90014496 in Participants With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma",
            "officialTitle": "A Phase Ib Multicenter, Open-Label, Study of JNJ-90014496, an Autologous CD19/CD20 Bi-specific CAR-T Cell Therapy in Adult Participants With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "a-study-of-jnj-in-participants-with-relapsed-or-refractory-b-cell-non-hodgkin-lymphoma"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-08-12",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-05-29",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2028-10-28",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-06-10",
            "studyFirstSubmitQcDate": "2022-06-13",
            "studyFirstPostDateStruct": {
                "date": "2022-06-16",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-16",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-18",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Janssen Research & Development, LLC",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a Phase Ib multicenter, open-label study of JNJ-90014496, an autologous bi-specific chimeric antigen receptor (CAR) T-cell therapy, targeting both cluster of differentiation (CD) CD19 and CD20 for the treatment of adult participants with relapsed or refractory B-Cell non-Hodgkin lymphoma (r/r B-NHL)."
        },
        "conditionsModule": {
            "conditions": [
                "Relapsed or Refractory B Cell Non-Hodgkin Lymphoma"
            ],
            "keywords": [
                "CD19/CD20-directed CAR-T Cells"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 104,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "JNJ-90014496",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive intravenous (IV) infusion of autologous JNJ-90014496 on Day 1.",
                    "interventionNames": [
                        "Biological: JNJ-90014496"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BIOLOGICAL",
                    "name": "JNJ-90014496",
                    "description": "JNJ-90014496, an autologous bi-specific chimeric antigen receptor (CAR) - T cell therapy targeting Cluster of differentiation (CD)19 and CD20.",
                    "armGroupLabels": [
                        "JNJ-90014496"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Occurrence of Adverse Events (AEs) [Safety and Tolerability]",
                    "description": "Occurrence of any AEs, including dose limiting toxicities (DLTs).",
                    "timeFrame": "Up to 24 months"
                },
                {
                    "measure": "Determination of the Recommended Phase 2 Dose (RP2D) of JNJ-90014496 in Participants with Relapsed or Refractory B-cell non-Hodgkin lymphoma (B-NHL)",
                    "description": "Based on the assessment of DLTs rates and overall safety profile.",
                    "timeFrame": "Up to 24 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Overall Response (OR)",
                    "description": "Complete response (CR) and partial response (PR) will be assessed by Lugano 2014 guidelines.",
                    "timeFrame": "Up to 24 months"
                },
                {
                    "measure": "Time to Response (TTR)",
                    "description": "The time from the date of JNJ-90014496 infusion to the first documented CR or PR will be assessed by Lugano 2014 guidelines.",
                    "timeFrame": "Up to 24 months"
                },
                {
                    "measure": "Duration of Response (DOR)",
                    "description": "The time from the first documented CR or PR to relapse or death, whichever occurs first will be assessed by Lugano 2014 guidelines.",
                    "timeFrame": "Up to 24 months"
                },
                {
                    "measure": "Pharmacokinetic Evaluation of JNJ-90014496",
                    "description": "JNJ-90014496 blood levels will be reported.",
                    "timeFrame": "Up to 24 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "* Participant must be greater than or equal to (\\>=) 18 years of age, at the time of signing informed consent\n* Diagnosis of mature aggressive large B cell non-Hodgkin lymphoma or follicular lymphoma\n* Tumor must be histologically confirmed cluster of differentiation (CD)19 and/or CD20 positive\n* Must have relapsed or refractory disease with the following indications for each histologic subtype: Mature aggressive large B cell non-Hodgkin lymphoma (NHL) and follicular lymphoma Grade 3b: Participants must have \\>= 2 lines of systemic therapy, or \\>= 1 line of systemic therapy for participants who are ineligible for autologous stem cell transplant; Follicular lymphoma Grade 1-3a and marginal zone lymphoma: Participants must have \\>= 2 prior lines of anti-neoplastic systemic therapy. Participants also must have prior exposure to an anti-CD20 monoclonal antibody\n* Measurable disease as defined by Lugano 2014 classification\n* Eastern cooperative oncology group (ECOG) performance status of either 0 or 1\n\nExclusion Criteria\n\n* Diagnosis of Human herpes virus (HHV) 8-positive diffuse large B Cell lymphoma (DLBCL)\n* Prior allogeneic hematopoietic stem cell transplantation (HSCT)\n* Autologous stem cell transplant within 12 weeks of chimeric antigen receptor (CAR) T cell infusion\n* Uncontrolled active infections\n* History of deep vein thrombosis or pulmonary embolism within six months of infusion (except for line associated deep vein thrombosis \\[DVT\\])\n* History of stroke, unstable angina, myocardial infarction, congestive heart failure New York Heart Association (NYHA) Class III or IV, severe cardiomyopathy or ventricular arrhythmia requiring medication or mechanical control within 6 months of screening\n* History of a seizure disorder, cerebrovascular ischemia/hemorrhage, dementia, cerebellar disease or neurodegenerative disorder\n* Known history or prior diagnosis of optic neuritis or other immunologic or inflammatory disease affecting the central nervous system\n* Current active liver or biliary disease (except for Gilbert's syndrome or asymptomatic gallstones)",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Study Contact, M.D.",
                    "role": "CONTACT",
                    "phone": "844-434-4210",
                    "email": "Participate-In-This-Study@its.jnj.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "John Baird, M.D.",
                    "affiliation": "City of Hope Medical Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "City of Hope",
                    "status": "RECRUITING",
                    "city": "Duarte",
                    "state": "California",
                    "zip": "91010",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.13945,
                        "lon": -117.97729
                    }
                },
                {
                    "facility": "Colorado Blood Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Denver",
                    "state": "Colorado",
                    "zip": "80218",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.73915,
                        "lon": -104.9847
                    }
                },
                {
                    "facility": "Rutgers Cancer Institute of New Jersey",
                    "status": "RECRUITING",
                    "city": "Piscataway",
                    "state": "New Jersey",
                    "zip": "08854",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.49927,
                        "lon": -74.39904
                    }
                },
                {
                    "facility": "Levine Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Charlotte",
                    "state": "North Carolina",
                    "zip": "28001",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 35.22709,
                        "lon": -80.84313
                    }
                },
                {
                    "facility": "University of Pittsburgh Medical Center",
                    "status": "RECRUITING",
                    "city": "Pittsburgh",
                    "state": "Pennsylvania",
                    "zip": "15232",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.44062,
                        "lon": -79.99589
                    }
                },
                {
                    "facility": "St. David's South Austin Medical Center",
                    "status": "RECRUITING",
                    "city": "Austin",
                    "state": "Texas",
                    "zip": "78704",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 30.26715,
                        "lon": -97.74306
                    }
                },
                {
                    "facility": "Texas Transplant Institute",
                    "status": "RECRUITING",
                    "city": "San Antonio",
                    "state": "Texas",
                    "zip": "78229",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.42412,
                        "lon": -98.49363
                    }
                },
                {
                    "facility": "Swedish Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Seattle",
                    "state": "Washington",
                    "zip": "98104",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 47.60621,
                        "lon": -122.33207
                    }
                },
                {
                    "facility": "St Vincents Hospital Melbourne",
                    "status": "RECRUITING",
                    "city": "Fitzroy",
                    "zip": "3065",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -37.79839,
                        "lon": 144.97833
                    }
                },
                {
                    "facility": "The Alfred Hospital",
                    "status": "RECRUITING",
                    "city": "Melbourne",
                    "zip": "3004",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -37.814,
                        "lon": 144.96332
                    }
                },
                {
                    "facility": "Fiona Stanley Hospital",
                    "status": "RECRUITING",
                    "city": "Murdoch",
                    "zip": "6150",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -32.06987,
                        "lon": 115.83757
                    }
                },
                {
                    "facility": "Calvary Mater Newcastle Hospital",
                    "status": "RECRUITING",
                    "city": "Waratah",
                    "zip": "2298",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -32.90667,
                        "lon": 151.72647
                    }
                },
                {
                    "facility": "Rigshospitalet",
                    "status": "RECRUITING",
                    "city": "Copenhagen",
                    "zip": "2100",
                    "country": "Denmark",
                    "geoPoint": {
                        "lat": 55.67594,
                        "lon": 12.56553
                    }
                },
                {
                    "facility": "Odense University Hospital",
                    "status": "RECRUITING",
                    "city": "Odense",
                    "zip": "5000",
                    "country": "Denmark",
                    "geoPoint": {
                        "lat": 55.39594,
                        "lon": 10.38831
                    }
                },
                {
                    "facility": "UMC Utrecht",
                    "status": "RECRUITING",
                    "city": "Utrecht",
                    "zip": "3584 CX",
                    "country": "Netherlands",
                    "geoPoint": {
                        "lat": 52.09083,
                        "lon": 5.12222
                    }
                },
                {
                    "facility": "Hosp Clinic de Barcelona",
                    "status": "RECRUITING",
                    "city": "Barcelona",
                    "zip": "08036",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "University College London Hospitals",
                    "status": "RECRUITING",
                    "city": "London",
                    "zip": "NW1 2BU",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 51.50853,
                        "lon": -0.12574
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008223",
                    "term": "Lymphoma"
                },
                {
                    "id": "D000008228",
                    "term": "Lymphoma, Non-Hodgkin"
                },
                {
                    "id": "D000016393",
                    "term": "Lymphoma, B-Cell"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000008232",
                    "term": "Lymphoproliferative Disorders"
                },
                {
                    "id": "D000008206",
                    "term": "Lymphatic Diseases"
                },
                {
                    "id": "D000007160",
                    "term": "Immunoproliferative Disorders"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M11220",
                    "name": "Lymphoma",
                    "asFound": "Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18828",
                    "name": "Lymphoma, B-Cell",
                    "asFound": "B-Cell Non-Hodgkin Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11222",
                    "name": "Lymphoma, Non-Hodgkin",
                    "asFound": "Non-Hodgkin Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M11225",
                    "name": "Lymphoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M11203",
                    "name": "Lymphatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10206",
                    "name": "Immunoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T3543",
                    "name": "Lymphosarcoma",
                    "asFound": "Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T640",
                    "name": "B-cell Lymphoma",
                    "asFound": "B-Cell Non-Hodgkin Lymphoma",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}